Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Sweden / NCT07606586
Starting soon Observational

Resilience and Recovery After Intimate Partner Violence - Evaluation of the EMBER-IPV Protocol

NCT07606586 · tracked via the Priya Life Science Sweden tracker
Sponsor
Uppsala University
Phase
Observational
Started
2026-05
Last updated
2026-05-26

Condition(s) studied

Intimate Partner ViolenceIntimate Partner Violence Against WomenShameDomestic AbuseResilience, Psychological

Investigational drug(s) / intervention(s)

Biopsychosocial Resilience Intervention for Women Subjected to IPV

Biopsychosocial Resilience Intervention for Women Subjected to IPV: A Resilience-Focused Intervention based on the Resilience Portfolio Model.

Study summary

The EMBER-protocol is an intervention used at the NCK clinic at Uppsala University Hospital with the purpose of helping women utilize their resilience and strengths in order to recover after intimate partner violence. This study is conducted in order to explore how health and resilience changes during the course of the EMBER-intervention. The participants are asked to complete questionnaires before, during and after the intervention.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Women taking part of the EMBER intervention (phase A or C) * Subjected to IPV within the past 2 years prior to enrollment Exclusion Criteria: * Ongoing severe intimate partner violence * Ongoing severe substance abuse * Severe mental health problems such as psychosis, suicidality

Primary outcome measure(s)

  • Well-Being — Data collection intervention A at 0 weeks and at completion (approximately 12-20 weeks); intervention C at 2 weeks pre-group and at start, middle and end of group intervention (0, 2 and 4 weeks); follow-up 6 weeks and 6 months post-group-intervention.
    Participants complete the self assessment questionnaire Questionnaire of Wellbeing (scale 0-72 points, higher value indicates higher level of wellbeing) in connection to a visit at the NCK Outpatient Clinic. Change from pre to post is analyzed using t-test and mixed effects models.

Trial sites (1)

FacilityCityRegionStatus
Uppsala University Hospital Uppsala Uppsala County

More Uppsala University trials in Sweden

Minimal Invasive Scoliosis or Open Surgery Starting soon
Validation of Pediatric Sleep Questionnaire on a Swedish Cohort Recruiting
Validation of the Swedish Translation of a Brief Shame Measure, the External and Internal Shame Scale Recruiting
Improved Oral Health in Head and Neck Cancer Survivors Recruiting
Fibromyalgia and Sleep Disorder Treatment Enrolling by invitation

Other trials for the same condition

Validation of the Swedish Translation of a Brief Shame Measure, the External and Internal Shame Scale Recruiting
Shame, Resilience and Well-being After Intimate Partner Violence: an Intervention Study With Replicated Single-Subject Design. Starting soon
How a Resilience-Focused Intervention is Perceived by Women Subjected to Domestic Violence Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07606586 on ClinicalTrials.gov ↗ ← All trials in Sweden